Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.39 Billion INR | 2.58% |
| 2022 | 2.33 Billion INR | 36.87% |
| 2021 | 1.7 Billion INR | 31.22% |
| 2020 | 1.29 Billion INR | -8.46% |
| 2019 | 1.41 Billion INR | 5.03% |
| 2018 | 1.34 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 2.39 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.38 Billion INR | 0.0% |
| 2023 FY | 2.39 Billion INR | 2.58% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 2.33 Billion INR | 36.87% |
| 2022 Q4 | 2.33 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.16 Billion INR | 0.0% |
| 2021 Q2 | 1.54 Billion INR | 5.47% |
| 2021 Q4 | 1.7 Billion INR | 0.0% |
| 2021 FY | 1.7 Billion INR | 31.22% |
| 2021 Q1 | 1.46 Billion INR | 12.79% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 1.29 Billion INR | -8.46% |
| 2020 Q4 | 1.29 Billion INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2019 FY | 1.41 Billion INR | 5.03% |
| 2018 FY | 1.34 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 55 Million INR | -4246.402% |
| Dr. Lal PathLabs Limited | 1.03 Billion INR | -132.089% |
| Metropolis Healthcare Limited | 1.19 Billion INR | -100.77% |
| Thyrocare Technologies Limited | 109.1 Million INR | -2091.128% |
| Vimta Labs Limited | 90.74 Million INR | -2534.473% |